Amyloid precursor protein gene analysis in familial Alzheimer's disease cases: A lack of mutations in exons 16 and 17

Folia Neuropathologica

Volumn 42, Issue 1, 2004, Pages 1-7

  Kowalska, Anna ^a   Pruchnik Wolińska, Danuta ^b   Florczak, Jolanta ^b   Szczech, Józef ^b   Kozubski, Wojciech ^b   Rossa, Grzegorz ^c   Wender, Mieczysław ^d  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c Prov Hosp Neurol/Psychiatric Dis   (Poland)

^d MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Alzheimer's disease; Amyloid precursor protein; APP gene; Genetic testing; Mutation screening; amyloid

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; EXON; FAMILIAL DISEASE; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; ONSET AGE; PATHOGENESIS; PEDIGREE ANALYSIS; POLAND; SAMPLING;

EID: 1942452812     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ancolio K, Dumanchin C, Barelli H, Warter JM, Brice A, Campion D, Frebourg T, Checler F (1999) Unusual phenotypic alteration of beta amyloid precursor protein (beta APP) maturation by a new Val-715→Met beta APP-770 mutation responsible for probable early-onset Alzheimer's disease. Proc Natl Acad Sci USA, 96: 4119-4124.
2. Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, Thomas-Anterion C, Michon A, Martin C, Chaarbonnier F, Raux G, Camuzat A, Penet C, Mesnage V, Martinez M, Clerget-Darpoux F, Brice A, Frebourg T (1999) Early-onset autosomal dominant Alzheimer's disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet, 65: 664-670.
3. Carter DA, Desmarais E, Bellis M, Campion D, Clerget-Darpoux F, Brice A, Agid Y, Jaillard-Serradt A, Mallet J (1992) More missense in amyloid gene. Nat Genet, 2: 255-256.
4. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M (1991) Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature, 353: 844-846.
5. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature, 360: 672-674.
6. Cras P, van Harskamp F, Hendriks L, Ceuterick C, Van Duijn CM, Stefanko SZ, Hofman A, Kros JM, Van Broeckohoven C, Martin JJ (1998) Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692 Ala-→Gly mutation. Acta Neuropathol (Berl), 96: 253-260.
7. Cruts M, Dermaut B, Kumar-Singh S, Rademakers R, Van den Broeck M, Van Broeckhoven C (2002) Novel German APP V715A mutation associated with presenile Alzheimer's disease. Neurobiol Aging, 23: S327.
8. Cruts M, van Duijn CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S, Sherrington R, Hutton M, Hardy J, St George-Hyslop PH, Hofman A, Van Broeckhoven C (1998) Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet, 7: 43-51.
9. Eckman CB, Mehta ND, Crook R, Perez-tur J, Prihar G, Pfeiffer E, Graff-Radford N, Hinder P, Yager D, Zenk B, Refolo LM, Prada CM, Younkin SG, Hutton M, Hardy J (1997) A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42 (43). Hum Mol Genet, 6: 2087-2089.
10. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 349: 704-706.
11. Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM (2001) Novel amyloid precursor protein mutation in an lowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol, 49: 697-705.
12. Hardy J, and Giggins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science, 256: 184-185.
13. Hardy J and Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297: 353-356.
14. Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, Warren A, McInnis MG, Antonarakis SE, Martin JJ, Hofman A, Van Broeckhoven C (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet, 1: 218-221.
15. Jarret JT and Lansbury PT Jr (1993) Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell, 73: 1055-1058.
16. Jones CT, Morris S, Yates CM, Moffoot A, Sharpe C, Brock DJ, St Clair D (1992) Mutation in codon 713 of the beta amyloid precursor protein gene presenting with schizophrenia. Nat Genet, 1: 306-309.
17. Kamino K, Orr HT, Payami H, Wijsman EM, Alonso ME, Pulst SM, Anderson L, O'dahl S, Nemens E, White JA (1992) Linkage and mutational analysis of familial Alzheimer's disease kindreds for the APP gene region. Am J Hum Genet, 51: 998-1014.
18. Kowalska A (2003) Amyloid precursor protein gene mutations responsible for early-onset autosomal dominant Alzheimer's disease. Folia Neuropathologica, 41: 43-48.
19. Kowalska A, Florczak J, Pruchnik-Wolinska D, Kraszewski A, Wender M (1998) Apolipoprotein E genotypes in sporadic early and late-onset Alzheimer's disease. Arch Immunol Therap Exp, 46: 177-181.
20. Kwok JB, Li QX, Hallupp M, Whyte S, Ames D, Beyreuther K, Masters CL, Schofield PR(2000) Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42 (43) peptide levels and induces apoptosis. Ann Neurol, 47: 249-253.
21. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GT, Luyenndijk W, Frangione B (1990) Mutation of the Alzheimer's disease amyloid gene in a hereditary cerebral hemorrhage, Dutch type. Science, 248: 1124-1126.
22. Liddell MB, Bayer AJ, Owen MJ (1995) No evidence that common allelic variation in the amyloid precursor protein (APP) gene confers susceptibility to Alzheimer's disease. Hum Molec Genet, 4: 853-858.
23. McKhann G, Drachman D, Folstein M (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA. Neurology, 34: 939-944.
24. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet, 1: 345-347.
25. Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science, 254: 97-99.
26. Murrell JR, Hake AM, Quaid KA, Farlow MR, Ghetti B (2000) Early-onset Alzheimer's disease caused by a new mutation (V717L) in the amyloid precursor protein gene. Arch Neurol, 57: 885-887.
27. Naruse S, Igarashi S, Kobayashi H, Aoki K, Inuzuka T, Kaneko K, Shimizu T, Iihara K, Kojima T, Miyatake T (1991) Missense mutation Val→lle in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet, 337: 978-979.
28. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, Näslund J, Lannfelt L (2001) The "Arctic" APP mutation (E693G) causes Alzheimer's disease by enhancing Aβ protofibril formation. Nature Neuroscience, 4: 887-893.
29. Pasalar P, Najmabadi H, Noorian AR, Moghimi B, Jannati A, Soltanzadeh A, Krefft T, Crook R, Hardy J (2002) An Iranian family with Alzheimer's disease caused by a novel APP mutation (Thr714Ala). Neurology, 58: 1574-1575.
30. Peacock MI, Warren JT Jr, Roses AD, Fink JK (1993) Novel polymorphism in the A4 region of the amyloid precursor protein gene in a patient without Alzheimer's disease. Neurology, 43: 1254-1256.
31. Peacock ML, Murman DL, Sima AA, Warren JT Jr, Roses AD, Fink JK (1994) Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease. Ann Neurol, 36: 432-438.
32. Selkoe DJ (1998) The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8: 447-452.
33. Steiner H, Haass C (2001) Nuclear signaling: a common function of presenilin substrates? J Mol Neurosci 17: 193-198.
34. Tagliavini F, Rossi G, Padovani A, Magoni M, Andora G, Sgarzi M, Bizzi A, Savoiardo M, Carella F, Morbin M, Giaccone G, Bugiani O (1999) A new (APP mutation related to hereditary cerebral haemorrhage. Alzheimer's Rep, 2: S28.
35. Tanzi RE, Vaula G, Romano DM, Mortilla M, Huang TL, Tupler RG, Wasco W, Hyman BT, Haines JL, Jenkins BJ, Kalaitsidaki M, Warren AC, McInnis MC, Antonarakis SE, Karlinsky H, Percy ME, Connor L, Growdon J, Crapper-Mclachlan DR, Gusella JF, St George-Hyslop PH (1992) Assessment of amyloid b-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet, 51: 273-282.
36. Zubenko GS, Farr J, Stiffler JS, Hughes HB, Kaplan BB (1992) Clinically-silent mutation in the putative iron-responsive element in exon 17 of the β-amyloid precursor protein gene. J Neuropath Exp Neurology, 51: 459-463.
37. Zubenko GS, Stiffler S, Farr J, Kopp U, Hughes H, Kaplan BB (1993) Lack of variation in the nucleotide sequence corresponding to the transmembrane domain of the β-amyloid precursor protein in Alzheimer's disease. Am J Med Genet, 48: 131-136.